Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
8-K

Report of unscheduled material events or corporate event

 View HTML
0001104659-17-073170.pdf
0001104659-17-073170.rtf
0001104659-17-073170.xls
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-17-009276.pdf
0001558370-17-009276.rtf
0001558370-17-009276.xls
424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

 View HTML
0001047469-17-007604.pdf
0001047469-17-007604.rtf
0001047469-17-007604.xls
4/A

Amendment to a previously filed 4

 View HTML
0001179110-17-014597.pdf
0001179110-17-014597.rtf
0001179110-17-014597.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-17-014599.pdf
0001179110-17-014599.rtf
0001179110-17-014599.xls
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-17-009050.pdf
0001558370-17-009050.rtf
0001558370-17-009050.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-17-014584.pdf
0001179110-17-014584.rtf
0001179110-17-014584.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-17-014585.pdf
0001179110-17-014585.rtf
0001179110-17-014585.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-17-014313.pdf
0001179110-17-014313.rtf
0001179110-17-014313.xls
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-17-008788.pdf
0001558370-17-008788.rtf
0001558370-17-008788.xls